| abstract |
Compounds of formula I n n n n n n n n n n wherein R 1 , L P , n, HetAr 1 , and HetAr 2 are as defined herein, and salts thereof, pharmaceutical compositions containing these compounds, and methods for treating diseases or conditions which are mediated by activating the G-protein-coupled receptor GPR119, such as diabetes, dislipidemia, or obesity, by administering to a patient in need thereof these compounds or a pharmaceutically acceptable salt thereof. |